1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide

C24H25ClN8O3 — CID 123902233

IUPAC1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide
SMILESO=C(Nc1cccnc1)C1CC(N2CCOCC2)CN1C(=O)C=Cc1cc(Cl)ccc1-n1cnnn1
InChIInChI=1S/C24H25ClN8O3/c25-18-4-5-21(33-16-27-29-30-33)17(12-18)3-6-23(34)32-15-20(31-8-10-36-11-9-31)13-22(32)24(35)28-19-2-1-7-26-14-19/h1-7,12,14,16,20,22H,8-11,13,15H2,(H,28,35)
InChIKeyDUDBQYDGMDMPLX-UHFFFAOYSA-N
MW508.97 g/mol
LogP1.66
Rot. Bonds6

About 1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide

1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide (PubChem CID 123902233) has the molecular formula C24H25ClN8O3 and a molecular weight of 508.97 g/mol. Its IUPAC name is 1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide.

Molecular Properties

Compound Name1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide
PubChem CID123902233
Molecular FormulaC24H25ClN8O3
Molecular Weight508.97 g/mol
Exact Mass508.17
IUPAC Name1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide
SMILESO=C(Nc1cccnc1)C1CC(N2CCOCC2)CN1C(=O)C=Cc1cc(Cl)ccc1-n1cnnn1
InChIInChI=1S/C24H25ClN8O3/c25-18-4-5-21(33-16-27-29-30-33)17(12-18)3-6-23(34)32-15-20(31-8-10-36-11-9-31)13-22(32)24(35)28-19-2-1-7-26-14-19/h1-7,12,14,16,20,22H,8-11,13,15H2,(H,28,35)
InChIKeyDUDBQYDGMDMPLX-UHFFFAOYSA-N
XLogP1.66
TPSA118.37 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500508.97
LogP ≤ 51.66
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide?
The IUPAC name of 1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide (CID 123902233) is 1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide.
What is the SMILES notation for 1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide?
The canonical SMILES for 1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide is O=C(Nc1cccnc1)C1CC(N2CCOCC2)CN1C(=O)C=Cc1cc(Cl)ccc1-n1cnnn1.
What is the InChIKey of 1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide?
The InChIKey is DUDBQYDGMDMPLX-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H25ClN8O3/c25-18-4-5-21(33-16-27-29-30-33)17(12-18)3-6-23(34)32-15-20(31-8-10-36-11-9-31)13-22(32)24(35)28-19-2-1-7-26-14-19/h1-7,12,14,16,20,22H,8-11,13,15H2,(H,28,35).
What are the key properties of 1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide?
1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide has a molecular weight of 508.97 g/mol, XLogP of 1.66, 6 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]-4-morpholin-4-yl-N-pyridin-3-ylpyrrolidine-2-carboxamide is sourced from PubChem (CID 123902233), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).